Skip to main content
Livermore
Livermore
ZHEN

Inventiva S.A.

IVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001756594

No open-market purchases or sales by Inventiva S.A. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $319.5M in total; no superinvestor holds it.

Other share classesIVEVF

Holders of 5% or more of IVA

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Inventiva S.A., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of IVA
HolderLatest formStakeChangeFirst filedLatest filingFiling
Invus Global Management, LLC13G/A10.60%14.8M shares+2.80 ppfrom 7.80%Mar 31, 20252 filingsJul 31, 2025SEC
Andera Partners13G/A8.80%12.3M shares+2.30 ppfrom 6.50%Apr 14, 20252 filingsAug 14, 2025SEC
Samsara BioCapital, L.P.13D/A7.40%13.5M shares+1.50 ppfrom 5.90%Oct 21, 20252 filingsNov 19, 2025SEC
Sofinnova Crossover I13G/A7.20%7.79M shares–Feb 14, 20251 filingFeb 14, 2025SEC
Eventide Asset Management, LLC13G6.70%10.1M sharesNewMay 15, 20251 filingMay 15, 2025SEC
Great Point Partners LLC13G/A6.06%8.64M shares−1.36 ppfrom 7.42%Jun 20, 20252 filingsNov 14, 2025SEC
New Enterprise Associates 17, L.P.13D/A6.00%8.35M shares–May 7, 20251 filingMay 7, 2025SEC
Yiheng Capital Management, L.P.13G/A5.46%7.60M shares−2.85 ppfrom 8.31%Nov 13, 20242 filingsNov 13, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

19 Schedule 13D and 13G filings on Inventiva S.A., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on IVA
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 19, 20258:52 PM ETSamsara BioCapital, L.P.and 4 others13D/A7.40%13.5M shares+1.50 ppfrom 5.90%Nov 17, 2025SEC
Nov 19, 20255:10 PM ETBiotechnology Value Fund L Pand 9 others13D/A4.99%9.57M shares−1.11 ppfrom 6.10%Below 5%Nov 17, 2025SEC
Nov 14, 20254:00 PM ETPerceptive Advisors LLCand 2 others13G/A4.99%7.30M shares−0.81 ppfrom 5.80%Below 5%Sep 30, 2025SEC
Nov 14, 20251:59 PM ETGreat Point Partners LLCand 2 others13G/A6.06%8.64M shares−1.36 ppfrom 7.42%Sep 30, 2025SEC
Nov 13, 202512:43 PM ETYiheng Capital Management, L.P.and 3 others13G/A5.46%7.60M shares−2.85 ppfrom 8.31%Sep 30, 2025SEC
Oct 21, 20254:07 PM ETSamsara BioCapital, L.P.and 2 others13D5.90%8.16M sharesNewMay 7, 2025SEC
Aug 14, 20254:13 PM ETAndera Partnersand 3 others13G/A8.80%12.3M shares+2.30 ppfrom 6.50%Jun 30, 2025SEC
Jul 31, 20252:48 PM ETInvus Global Management, LLCand 4 others13G/A10.60%14.8M shares+2.80 ppfrom 7.80%Jun 30, 2025SEC
Jun 20, 202512:47 PM ETGreat Point Partners LLCand 2 others13G7.42%10.6M sharesNewMay 5, 2025SEC
May 15, 20254:45 PM ETEventide Asset Management, LLCand 2 others13G6.70%10.1M sharesNewMay 9, 2025SEC
May 9, 20255:50 PM ETBiotechnology Value Fund L Pand 9 others13D/A6.10%8.55M shares−2.90 ppfrom 9.00%May 7, 2025SEC
May 7, 20258:03 PM ETNew Enterprise Associates 17, L.P.and 15 others13D/A6.00%8.35M shares–May 7, 2025SEC
Apr 14, 20256:13 PM ETAndera Partnersand 3 others13G6.50%6.15M sharesNewOct 17, 2024SEC
Mar 31, 20255:04 PM ETInvus Global Management, LLCand 4 others13G7.80%7.41M sharesNewOct 17, 2024SEC
Mar 26, 20254:56 PM ETPerceptive Advisors LLCand 2 others13G5.80%5.56M sharesNewDec 13, 2024SEC
Feb 14, 20254:20 PM ETSofinnova Crossover Iand 6 others13G/A7.20%7.79M shares–Dec 31, 2024SEC
Feb 14, 20254:05 PM ETBroqua Pierre13G/A4.30%4.10M shares–Below 5%Dec 31, 2024SEC
Dec 23, 20249:25 PM ETBiotechnology Value Fund L Pand 9 others13D/A9.00%8.55M shares–Dec 19, 2024SEC
Nov 13, 202412:26 PM ETYiheng Capital Management, L.P.and 3 others13G/A8.31%4.33M shares–Sep 30, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Inventiva S.A. shares.

No Form 144 notices for Inventiva S.A. are on file.